Follow
Nicola Fossati
Nicola Fossati
Verified email at hsr.it
Title
Cited by
Cited by
Year
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, J Bellmunt, M Bolla, E Briers, MG Cumberbatch, M De Santis, ...
European urology 71 (4), 618-629, 2017
37842017
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 243-262, 2021
24842021
Mortality after surgery in Europe: a 7 day cohort study
RM Pearse, RP Moreno, P Bauer, P Pelosi, P Metnitz, C Spies, B Vallet, ...
The Lancet 380 (9847), 1059-1065, 2012
14752012
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 263-282, 2021
9212021
The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review
N Fossati, PPM Willemse, T Van den Broeck, RCN van den Bergh, ...
European urology 72 (1), 84-109, 2017
5362017
Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review
T Van den Broeck, RC Van Den Bergh, N Arfi, T Gross, L Moris, E Briers, ...
European urology 75 (6), 967-987, 2019
4772019
What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the …
PC Moldovan, T Van den Broeck, R Sylvester, L Marconi, J Bellmunt, ...
European urology 72 (2), 250-266, 2017
4082017
EAU–ESTRO–ESUR–SIOG guidelines on prostate cancer
N Mottet, J Bellmunt, E Briers, M Bolla, L Bourke, P Cornford, M De Santis, ...
European Association of Urology, 2018
3852018
Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer
F Abdollah, RJ Karnes, N Suardi, C Cozzarini, G Gandaglia, N Fossati, ...
Journal of clinical oncology 32 (35), 3939-3947, 2014
3642014
Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review
M Lardas, M Liew, RC van den Bergh, M De Santis, J Bellmunt, ...
European urology 72 (6), 869-885, 2017
2892017
A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance …
G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori, N Fossati, ...
European urology 75 (3), 506-514, 2019
2822019
Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies
A Necchi, D Raggi, A Gallina, R Madison, M Colecchia, R Luciano, ...
European urology 77 (4), 439-446, 2020
2812020
EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international …
TBL Lam, S MacLennan, PPM Willemse, MD Mason, K Plass, R Shepherd, ...
European urology 76 (6), 790-813, 2019
2452019
Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer
G Gandaglia, N Fossati, E Zaffuto, M Bandini, P Dell’Oglio, CA Bravi, ...
European urology 72 (4), 632-640, 2017
2292017
Biochemical recurrence in prostate cancer: the European Association of Urology prostate cancer guidelines panel recommendations
T Van den Broeck, RCN van den Bergh, E Briers, P Cornford, ...
European urology focus 6 (2), 231-234, 2020
1952020
Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study
N Fossati, QD Trinh, J Sammon, A Sood, A Larcher, M Sun, P Karakiewicz, ...
European urology 67 (1), 3-6, 2015
1852015
Long-term followup and deterioration rate of anterior substitution urethroplasty
G Barbagli, SB Kulkarni, N Fossati, A Larcher, S Sansalone, G Guazzoni, ...
The Journal of urology 192 (3), 808-813, 2014
1722014
Benefits and risks of primary treatments for high-risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review
L Moris, MG Cumberbatch, T Van den Broeck, G Gandaglia, N Fossati, ...
European urology 77 (5), 614-627, 2020
1552020
Impact of molecular subtyping and immune infiltration on pathological response and outcome following neoadjuvant pembrolizumab in muscle-invasive bladder cancer
A Necchi, D Raggi, A Gallina, JS Ross, E Farč, P Giannatempo, ...
European urology 77 (6), 701-710, 2020
1512020
Active surveillance for low-risk prostate cancer: the European Association of Urology position in 2018
A Briganti, N Fossati, JWF Catto, P Cornford, F Montorsi, N Mottet, M Wirth, ...
European urology 74 (3), 357-368, 2018
1442018
The system can't perform the operation now. Try again later.
Articles 1–20